Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @embase
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @embase
-
Learn with Dr. Andrey Khudoshin about data-driven drug re-purposing approaches for anti-viral and anti-bacterial drug R&D. Join the webinar on 30th April 2020 at 15:00 CEST/09:00 EST https://bit.ly/2zeoDnQ pic.twitter.com/n2LesoOot1
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Phenotypic similarities of conserved genetic domains among viruses can highlight targets and potential drug candidates. Fast track your efforts to develop
#COVID19 therapies or vaccines – these are the concrete examples proposed by@Paul Dockerty: https://bit.ly/3eEoD0C pic.twitter.com/fNAZjykNkV
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Learn all about the ACC COVID-19 resource hub in this engaging webinar with with Dr. Thomas M Maddox (MD MsC), Chair of the American College of Cardiology’s Science and Quality committee. Sign Up here:
@JACCJournals@ACCinTouch https://bit.ly/3cBxpL2 pic.twitter.com/kq14hKZEtC
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Join the engaging webinar to learn best practices for submitting research in highly-selective journals with Dr. Robert D. Eagling, editor-in-chief, Chem,
@CellPressNews .Sign Up: https://bit.ly/3bofVSc pic.twitter.com/Gedu9wgTmk
Thanks. Twitter will use this to make your timeline better. UndoUndo -
The search for a
#COVID19 treatment continues. A new analysis aims to identify the effects of#hydroxychloroquine,#chloroquine and#azithromycin on proteins known to be up-regulated by severe#ARDS using Elsevier’s Biology Knowledge Graph. Read more: https://bit.ly/2VHAHWl pic.twitter.com/fqGhzlPEBN
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Join Dr. Robert D. Eagling, editor-in-chief,
@Chem_CP , a Cell Press Journal to learn the best practices in submitting your research for highly-selective journals. Claim your seat: https://bit.ly/3cACtzx pic.twitter.com/46HuS3IvED
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Learn all about the American College of Cardiology’s COVID-19 Resource Hub with Dr. Thomas M Maddox (MD MsC), Chair of the American College of Cardiology’s Science and Quality committee. Claim Your Free Seat here:
@ACCinTouch https://bit.ly/2VElzc6 pic.twitter.com/DVkRsA2AAX
Thanks. Twitter will use this to make your timeline better. UndoUndo -
We’re collaborating with
@ExactCure to develop#AI powered personalized model simulations to improve the dosing of#COVID-19 related therapies like#Hydroxychloroquine and#Chloroquine: Read more about this in@scwmagazine https://bit.ly/3bfN9mI pic.twitter.com/kC7pPV4SLX
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Learn the best practices in submitting your research for highly-selective journals with Dr. Robert D. Eagling, editor-in-chief, Chem, a Cell Press Journal. Sign up here: https://bit.ly/3etzxGq pic.twitter.com/qLjs5MRhcC
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Discovering drugs to treat COVID-19? Our
#ProfessionalServices Director Anton Yuryev has updated his article “Three Drug development strategies to combat 2019 novel coronavirus”. Link: https://bit.ly/34I6St2#covid19#PAMemberNews#DrugDiscovery#DrugResearch#LifeSciencespic.twitter.com/107pw5G0Ky
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Discover how Embase can be used by researchers to uncover important findings from grey literature.
#greyliterature#conferenceabstracts#raredisease Read the blog post now https://bit.ly/2K1B3BB pic.twitter.com/5jaXleES1X
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Introducing one of our newest Reaxys Advisory Board members, Prof Donna M. Huryn of the University of Pittsburgh, in this recent interview: https://bit.ly/3b0Eqoe
@dmhuryn@PittTweet#WomenInSTEM#ReaxysPhDPrizepic.twitter.com/MTTsz7Hc4o
Thanks. Twitter will use this to make your timeline better. UndoUndo -
With the spread of
#coronavirus throughout the globe, scientists are testing traditional Chinese medicine in clinical trials. Scientific literature is key to providing evidence.#traditional#medicine#clinicaltrials#PAMemberNews Learn more: https://bit.ly/2RnZbCT pic.twitter.com/H8becDJ7Tl
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Check out these 3 drug development strategies for fighting the novel coronavirus: https://bit.ly/2QJTYoA pic.twitter.com/S0eDk0HAeO
Thanks. Twitter will use this to make your timeline better. UndoUndo -
What are 3 additional impacts of the
#coronavirus#COVID-19 outbreak that global pharma should prepare for? https://bit.ly/2WBCZIx pic.twitter.com/WLAPNu6voK
Thanks. Twitter will use this to make your timeline better. UndoUndo -
With the rapid spread of
#COVID-19 around the globe, traditional Chinese medicine is being tested in clinical trials, and being examined in systematic reviews. Read more: https://bit.ly/2Uri7Bh pic.twitter.com/adEC6NgBcK
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Join us tomorrow! Dr. Anton Yuryev, Biology Director at
@ElsevierConnect will talk about how to use Biomedical Knowledge Graph and AI#tools for drug discovery, personalized treatment and neoantigen#vaccine design: http://bit.ly/2TDxYgV pic.twitter.com/Av969BvjHZ
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Beijing University of Chinese Medicine and
@ElsevierConnect have launched the first#acupuncture branch of Traditional Chinese Medicine#taxonomy. This will help scientists overcome historical difficulties surrounding research into TCM: http://bit.ly/38svQg3#clinicalsolutionspic.twitter.com/KzadhMCxJy
Thanks. Twitter will use this to make your timeline better. UndoUndo -
Today we’re announcing a new initiative that integrates data from the Global Medical Device Nomenclature (GMDN) Agency into
@ElsevierConnect Embase database, helping organizations comply with EU regulations around device safety: http://bit.ly/2vMOvpg#compliance#medicaldeviceThanks. Twitter will use this to make your timeline better. UndoUndo -
Join Umesh Nandal, a Machine Learning and Natural Language Scientist, as he presents his work on the automated extraction of Adverse Drug Reactions from biomedical literature. Join the live webinar on Feb 19th, at 16:00 CET http://bit.ly/2uZ6HMn
#AI#DrugSafety#ADR#NLPpic.twitter.com/ZbJCMIh4Q9
Thanks. Twitter will use this to make your timeline better. UndoUndo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

